Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Anticancer Research|January 29, 2018
Phase II Study of S-1 plus Trastuzumab for HER2-positive Metastatic Breast Cancer (GBCCSG-01)Takaaki Fujii, Jun Horiguchi, Yasuhiro Yanagita, et al.
Water Research|February 4, 2016
Occurrence and partition ratios of radiocesium in an urban river during dry and wet weather after the 2011 nuclear accident in FukushimaMichio Murakami, Nao Shibayama, Keisuke Sueki, et al.
In Vivo (Athens, Greece)|November 4, 2020
Implications of Topoisomerase (TOP1 and TOP2α) Expression in Patients With Breast CancerMisato Ogino, Takaaki Fujii, Yuko Nakazawa, et al.
Oncology Reports|December 5, 2003
DPD activity and immunohistochemical DPD expression in human breast cancerJun Horiguchi, Takashi Yoshida, Yukio Koibuchi, et al.
Chemosphere|August 30, 2017
Source analysis of radiocesium in river waters using road dust tracersMichio Murakami, Mahua Saha, Yuichi Iwasaki, et al.
Oncology Reports|August 9, 2002
Breast-conserving surgery following radiation therapy of 50 Gy in stages I and II carcinoma of the breast: the experience at one institute in JapanJun Horiguchi, Yukio Koibuchi, Hiroyuki Takei, et al.
The Breast Journal|September 9, 2006
Human leukocyte antigen as a predictive factor of developing bilateral breast cancer in Japanese womenTakao Yokoe, Jun Horiguchi, Yukio Koibuchi, et al.
International Journal of Molecular Medicine|November 13, 2003
Immunohistochemical double staining with estrogen receptor and HER2 on primary breast cancerJun Horiguchi, Yukio Koibuchi, Kotaro Iijima, et al.
Anticancer Research|June 3, 2006
Significance of local recurrence as a prognostic factor in the treatment of breast cancerJun Horiguchi, Yukio Koibuchi, Takashi Yoshida, et al.
Breast Cancer (Tokyo, Japan)|June 12, 2026
Changes in CD8-positive lymphocytes following chemotherapy with concomitant bevacizumab in HER2-negative breast cancerEriko Narusawa, Ayaka Katayama, Yukio Koibuchi, et al.
Pageof 4